
|Videos|November 5, 2021
Phosphate Binder Treatment Benefits Individuals With Advanced Stages of Chronic Kidney Disease
Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, discusses what the treatment options are to treat vascular calcification.
Advertisement
In a Pharmacy Times® interview, Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, about his ASN 2021 Kidney Week presentation on the prevention of vascular calcification in chronic kidney disease.
He discussed what the treatment options are to treat vascular calcification.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
Dosing, Monitoring, and Counseling: The Pharmacist's Role in TKI Therapy for Systemic Mastocytosis
4
What Pharmacists Should Know About the Ifosfamide Shortage
5





































































































